期刊文献+

α-菠菜甾醇对小鼠小肠段药物转运体P-gp和PEPT1表达的影响

Influence of α-spinasterol on expression of P-gp and PEPT1 in small intestine of mice
下载PDF
导出
摘要 以酒石酸泰乐菌素为底药,探讨α-菠菜甾醇对小鼠小肠段药物转运体P-gp和PEPT1表达的影响。48只小鼠分为4组:α-菠菜甾醇组,酒石酸泰乐菌素组,α-菠菜甾醇和酒石酸泰乐菌素混合组,生理盐水对照组。每组按0.2 m L·10 g^(-1)体质量的剂量每天灌胃一次,共灌胃5 d,分别在1,3,5 d后处死1批采样。采用免疫组化的方法测定1,3,5 d的小鼠肠道上P-gp和PEPT1的表达。试验结果表明,α-菠菜甾醇组和混合组相对于对照组外排性药物转运体P-gp表达减少,而摄取性药物转运体PEPT1表达增多;酒石酸泰乐菌素组的外排性药物转运体P-gp表达增多,摄取性药物转运体PEPT1表达减少;且都随着用药时间的延长差异增大。表明α-菠菜甾醇具有抑制药物转运体P-gp表达和促进药物转运体PEPT1表达的作用。 In order to research the effect of α-spinasterol on the intestine transporters P-gp and PEPT1 when the ty-lenol tartrate was introduced as a substrate, 48 mice were equally divided into 4 treatment groups: α-spinasterol group, tylenol tartrate group, mixed (α-spinasterol and tylenol tartrate) group, and normal saline group which was used as control group. The formulations were administered by oral gavage with a dose of 0. 2 mL·10 g^-1 depending on body weight of mice. The small intestine samples of the dissected mice were excised at predetermined time inter-vals (1, 3, 5). The expressions of P-gp and PEPT1 on the mice intestines were detected by immunohistochemical method at 1, 3, 5 d, respectively. The results showed that the protein expression of P-gp was distinctly reduced inα-spinasterol and mixed groups, and the protein expression of PEPT1 was increased in these 2 groups compared with normal saline group. However, the protein expression of P-gp was increased and the protein expression of PEPT1 was decreased in tylenol tartrate group compared with normal saline group. The difference was more obvious with time pass by. In summary, α-spinasterol had an obvious impact on intestine transporters, including inhibiting P-gp ex-pression and inducing PEPT1 expression.
出处 《浙江农业学报》 CSCD 北大核心 2016年第6期944-950,共7页 Acta Agriculturae Zhejiangensis
基金 国家自然科学基金项目(31272599)
关键词 α-菠菜甾醇 小鼠 药物转运体 P-GP PEPT1 α-spinasterol mice drug transporter P-gp PEPT1
  • 相关文献

参考文献19

  • 1钟运鸣,王素军,杨本坤,曾洁,臧林泉.肠道转运体在药物吸收中作用的研究进展[J].广东药学院学报,2013,29(4):458-461. 被引量:6
  • 2朱宝英,黄静,王永林,方翼.P-糖蛋白及肿瘤多药耐药的逆转[J].中国药房,2011,22(6):550-552. 被引量:25
  • 3ANDERLE P, NIEDERER E, RUBAS W, et al. P-Glycopro- tein(P-gp) mediated efflux in Caeo-2 cell monolayers: the in- fluence of culturing conditions and drug exposure on P-gp ex- pression levels [ J ]. Journal of Pharmaceutical Sciences, 1998, 87(6) . 757 -762.
  • 4LOHNER K,SCHNABELE K, DANIEL H, et al. Flavonoids alter P-gp expression in intestinal epithelial cells in vitro and in vivo [J]. Molecular Nutrition & Food Research, 2007, 51 (3) : 293 - 300.
  • 5BRANDSCH M, KNITI'ER I, BOSSE-DOENECKE E. Phar- maceutical and pharnacological importance of peptide trans- porters [J]. Journal of Pharmacy & Pharmacology, 2008, 60 (5) : 543 -585.
  • 6潘树矿,张令达.多药耐药糖蛋白p-glycoprotein及其抑制剂的研究进展[J].广东牙病防治,2007,15(5):236-238. 被引量:3
  • 7王庆端,韩立,江金花.植物来源的P糖蛋白抑制剂研究进展[C]//2013医学前沿论坛暨第十三届全国肿瘤药理与化疗学术会议论文集.洛阳:中国工程院医药卫生学部和中国抗癌协会抗癌药物专业委员会、中国药理学会肿瘤药理号业委员会.2013.
  • 8李峥,庄笑梅,李素云,张振清,阮金秀.P-糖蛋白中药抑制剂的研究进展[J].解放军药学学报,2009,25(4):326-329. 被引量:16
  • 9REN J, ZOU M, GAO P, et al. Tissue distribution of bomeol- modified gancielovir-loaded solid lipid nanopartieles in mice af- ter intravenous administration [ J]. European Journal of Phar- maceutics & Biopharmaceutics, 2013, 83 (2) : 141 - 148.
  • 10TREVISAN G, ROSSATO M F, WALKER C I, et al. Iden- tification of the plant steroid ct-spinasterol as a novel transient receptor potential vanilloid 1 antagonist with antinoeieeptive properties [ J ]. Journal f Pharmacology & Experimental Therapeutics, 2012, 343(2) : 258 -269.

二级参考文献60

共引文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部